ASCO updates guidance on prophylaxis for adults with cancer-related immunosuppressionSeptember 7, 2018Indolent Lymphoma
Rituximab/lenalidomide similar to rituximab/chemotherapy for follicular lymphomaSeptember 6, 2018Indolent Lymphoma
FDA approves ibrutinib with rituximab in Waldenström’s macroglobulinemiaAugust 27, 2018Indolent Lymphoma
Venetoclax plus ibrutinib yields encouraging MRD results in first-line CLLJune 8, 2018Indolent Lymphoma
